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Abstract
Background: Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant inherited disease characterized by
gastrointestinal hamartomatous polyps and mucocutaneous melanin spots. Germline mutation of the serine/
threonine kinase 11 (STK11) gene are responsible for PJS. In this study, we investigated the clinical characteristics
and molecular basis of the disease in Chinese children with PJS.
Methods: Thirteen children diagnosed with PJS in our hospital were enrolled in this study from 2011 to 2015, and
their clinical data on polyp characteristics, intussusceptions events, family histories, etc. were described. Genomic
DNA was extracted from whole-blood samples from each subject, and the entire coding sequence of the STK11
gene was amplified by polymerase chain reaction and analyzed by direct sequencing.
Results: The median age at the onset of symptoms was 2 years and 4 months. To date, these children have
undergone 40 endoscopy screenings, 17 laparotomies and 9 intussusceptions. Polyps were found in the stomach,
duodenum, small bowel, colon and rectum, with large polyps found in 7 children. Mutations were found in eleven
children, including seven novel mutations (c.481het_dupA, c.943_944het_delCCinsG, c.397het_delG, c.862 + 1G > G/A,
c.348_349het_delGT, and c.803_804het_delGGinsC and c.121_139de l19insTT) and four previously reported mutations
(c.658C > C/T, c.890G > G/A, c.1062 C > C/G, and c.290 + 1G > G/A). One PJS patient did not have any STK11 mutations.
Conclusions: The polyps caused significant clinical consequences in children with PJS, and mutations of the STK11
gene are generally the cause of PJS in Chinese children. This study expands the spectrum of known STK11 gene
mutations.
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Background
Peutz-Jeghers syndrome (PJS, OMIM 175200) is a rare
inherited autosomal dominant disorder characterized by
mucocutaneous pigmentation (MP), hamartomatous
polyposis and an increasing risk of developing cancer.
The main clinical symptoms of this syndrome include
abdominal pain, rectal blood loss, anemia, small bowel
obstruction, and intussusception, leading to a high endo-
scopic and surgical resection rates. The first case of PJS
was recognized by Peutz in 1921 in a Dutch family, and
Jeghers et al. described the characteristics of this
disorder in another family in 1948 [1]. PJS polyps
commonly present in adolescence and early adulthood.
One-third of affected individuals experience symptoms
during the first 10 years of life [2]. Patients with PJS are
at an increased risk of developing gastrointestinal cancer
and extraintestinal neoplasms involving organs such as
the ovaries, testes, breasts, pancreas, lungs, and uterine
cervix [3].
The incidence of this disease has been estimated to be
approximately 1 in 8,300 to 1 in 200,000 births. A germ-
line mutation of the STK11 gene (also named LKB1),
which is located on chromosome 19p13.3, is responsible
for PJS. The STK11 gene consists of a 433-amino acid
coding sequence comprised of nine coding exons and
one non-coding exon.
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To date, few studies have reported the clinical character-
istics and STK11 gene of Chinese children with PJS [4]. In
this study, we focused on the clinical characteristics and the
detection of pathogenic germline mutations in Chinese
children with PJS and their available family members in
order to expand the spectrum of PJS gene mutations.
Methods
Patient and sample collection
The study protocol was approved by the ethics commit-
tee of the Children’s Hospital of Fudan University in
Shanghai, China. The consent was obtained from all the
parents for this study. Furthermore, consent to publish
personal information such as that contained in Table 2
was also obtained from all the participants’ parents.
"Thirteen children were enrolled in this study, including
eleven boys and two girls, from February 2011 to February
2015. The ages of the children when they were diagnosed
with the disease ranged from 16 month to 15 years old,
and the age of disease onset ranged from birth to 5 years
old. Blood samples were collected from four Chinese PJS
families and eight sporadic patients.
Clinical diagnosis criterion: Each clinical diagnosis was
made according to the following clinical criteria, and a
patient presenting any one of the following symptoms
was considered affected [5]:
1. Two or more histologically confirmed Peutz-Jeghers
polyps.
2. Any number of Peutz-Jeghers polyps detected in one
individual with a family history of PJS in a close
relative(s).
3. Characteristic MP in an individual with a family
history of PJS in a close relative(s).
4. Any number of Peutz-Jeghers polyps in an individual
who also has characteristic MP.
Endoscopy was performed to survey the children with
PJS who had multiple polyps in the gastrointestinal
tracts (Fig. 1). Various authors have proposed defining
“large” polyps as 1 cm and “giant” polyps as those meas-
ure 2-cm and 3-cm in size [6–9]. In our study, polyps
were classified as “large” if >1 cm in size and “giant”
if >2 cm in size. The polyps were removed by poly-
pectomy under endoscopy or laparotomy.
Genomic DNA isolation and polymerase chain
reaction (PCR)
Genomic DNA was extracted routinely from venous
blood using an Isolation Kit (Qiagen, Germany) according
to the manufacturer’s instructions. All nine coding exons
and the flanking introns of the STK11 gene were amplified
using the primers listed in Table 1. PCR of STK11 exons
was performed in a 20-μl reaction volume that contained
10 μl of 2× PCR buffer, 3.2 μl of 0.25 mmol/l dNTPs,
0.5 μl of 10 μmol/l of each primer, 40 ng of genomic
DNA, and 2 U Taq DNA polymerase (Takara LA Taq).
PCR was performed under the following conditions:
denaturation at 94 °C for 4 min, followed by 40 cycles at
94 °C for 30 s, 68 °C for 30 s, and 72 °C for 45 s.
DNA sequencing
The PCR products were gel- and column-purified and
directly sequenced. The purified PCR fragments were
Fig. 1 Endoscopy images of polyps in PJS patients. a-c Case 5 had polyps in the gastric body, duodenal bulb and transverse colon; d-f Case 8
had polyps in the gastric fundus, duodenal descending part and sigmoid colon
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then sequenced using BigDye Terminator (Applied
Biosystems, Foster City, CA, USA) on an ABI Prism
3500 genetic analyzer (Applied Biosystems).
Bioinformatics analysis
Mutation Taster (http://www.mutationtaster.org/) was
used to evaluate the disease-causing potential of the se-
quence alterations. We described the nucleotide and
amino acid position in the STK11 gene according to the
NCBI reference sequence (NG_007460.1).
Results
Clinical characters of children with PJS
These PJS children are from thirteen unrelated Chinese
families from different area of China. Case 1 was from
Anhui Province; Cases 3, 6 and 9 are from Jiangxi
Province; Case 4 was from Zhejiang Province; Case 8
was from Shanghai; and Cases 10, 11 and 13 were from
Jiangsu Province. All of these places are in eastern
China. Case 2 was from Hunan Province, which is in
south central China. Case 5 was from Sichuan Province,
and Case 12 was from Hainan Province; both of these
provinces in southwest China. Case 7 was from Gansu
Province, which is in northwest of China.
The present age of children ranged from 2 to 17 years,
and group included eleven boys and two girls. The
clinical data, reasons for initial evaluation, clinical com-
plication, etc. are shown in Table 2. The reasons for the
children’s initial evaluations in our hospital are as
follows, bloody stool (2/13), prolapsed polyps (1/13), in-
tussusceptions (5/13), family history of PJS (4/13), MP
(12/13) and anemia (3/13).
The median age at the onset of symptom was 2 years
and 4 months. The median age at first screening test
was 6.5 years (range 1–13 years). To date, there have
been 40 endoscopy screenings (9 outside our hospital),
4 capsule endoscopies (1 outside our hospital), 17
laparotomies (5 outside our hospital), 9 intussusceptions
(4 outside our hospital), and 2 intestinal obstructions
(1 outside our hospital) in these children. In the
group of children, 9 children had underwent laparoto-
mies, 2 had underwent two laparotomies and 3 had
underwent three laparotomies.
Large polyp location and size
The thirteen children presented with variety of gastro-
intestinal polyps. During follow –up visits, polyps were
located in the gastric body, antrum, duodenal bulb,
descending duodenum, small bowel, transverse colon,
descending colon, sigmoid and rectum. Case 1 had two
large polyps in the sigmoid (4 × 3 cm) and stomach
(2.3 × 1 cm), which were removed by polypectomy under
endoscopy; a giant polyp in the stomach (12 × 6 cm) was
removed by laparotomy. Case 2 had one giant polyp in
the stomach (7 × 8 cm), which was removed by laparot-
omy. Case 3 required surgical intervention due to
intussusception, which revealed 3 large polys of approxi-
mately 5 cm in diameter. Case 5 had two large polyps in
the duodenal bulb (1.5 × 2 cm and 1 × 1 cm). Case 6 had
two giant polyps in the descending part of the duode-
num (3 × 0.5 cm, 2.5 × 2 cm) that were treated by endo-
scopic resection. Case 10 had a giant lobulated polyp in
the sigmoid (4 × 2 cm) that was also removed under en-
doscopy. Case 11 had a giant polyp in the left colic flex-
ure (3.5 × 6.8 cm). Case 12 presented with many polyps
in the sigmoid colon, descending colon, ascending colon,
et al.; and a total number of 9 large polyps with diame-
ters ranging from 1 to 4 cm were removed by laparot-
omy or endoscopic resection separately. Case 13 showed
only many small polyps in the small bowel under capsule
endoscopy screen.
Mutation analysis
STK11 gene sequence analyses were performed for
twelve of the thirteen pediatric PJS patients (Table 3).
We identified eleven mutations, including seven novel
mutations (four of which were de novo mutations) and
four previously reported mutations (two of which were
de novo mutations); one patient (Case 10) did not have
any STK11 gene mutations. and Case 13 did not receive
the genetic test. The seven novel mutations included six
frameshift mutations (Case 1: 481het_dupA, Case 3:
c.943_944 het_del CCinsG, Case 4: c.397het_delG,
Case 9: c.348_349het_delGT, Case 11: c.803_804 het_del
GG insC, and Case 12: c.121_139del19insTT) and one
splice site mutation (Case 6: c.862 + 1G >G/A). The four
previously reported mutations included one nonsense mu-
tation (Case 2: c.658C > C/T), two missense mutations
(Case 5: c.890G >G/A and Case 7: c.1062C > C/G), and
one splice site mutation (Case 8: c.290 + 1 G >G/A)
(Fig. 2).
Regarding these novel mutations, Case 1 had an A
base insertion at exon 4 (481het_dupA) that caused a
Table 1 Primers for exon-specific sequencing of the STK11 gene
Exon Forward Reverse Base
Exon 1 tccttttggggtttttgttg ctggcacggaggacacag 576
Exon 2 tcccacagcactgtgaactc attgccacaatggctgactt 394
Exon 3 ttcagaggggtggctgag cagaagaatggcgtgaacct 488
Exon 4 gtgtgcctggacttctgtga ccaccatctgccgtatgag 649
Exon 5 gtgtgcctggacttctgtga ccaccatctgccgtatgag 649
Exon 6 ggtgtccttgagtccacagg cagtcctctcaatgcctgct 384
Exon 7 ggagtggagtggcctctgt acaggacactgcccagaga 400
Exon 8 atggctgagcttctgtggtc ctttggggacgtgggatt 471
Exon 9 ggatacacctgggcctgac caaaggccacatggcaac 485
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Initial evaluation Finding at first endoscopy/ surgery Polyposis clinical complications
Age (y) Reason Age (y) Method Location Size-no Intussusception Surgery Anemia Bloody stool Abdominal pain PRP
1 (M) 9 No 7 MP 7 EGD, Col GD, Colon Large-2 - yes - - - -
2 (M) 9 No 5 MP, anemia 5 EGD GD Large-1 - yes 62.2 g/L - - -
3 (F) 7 No 3 MP, abdominal pain 3 Laparotomy SB Large-1 yes yes - - yes -
4 (M) 13 No 9 MP, bloody stool 9 EGD, Col GD, Colon NA yes yes - - - -
5 (M) 15 Yes 13 MP, bloody stool 13 EGD, Col GD, Colon Large-1 - - 81 g/L - - -
6 (M) 11 Yes 9 MP, abdominal pain 9 Col Colon NA yes yes - - yes -
7 (M) 7 No 7 MP, abdominal pain 7 Laparotomy SB NA yes yes 99 g/L - - -
8 (M) 15 Yes 8 FH,MP 8 Col Col Small - - - yes - -
9 (M) 17 No 8 MP, abdominal pain 8 x-ray GD, Colon unknown yes yes - - yes -
10 (M) 2 No 1 PRP 1 Col Colon Large-1 - - - - - yes
11 (M) 7 Yes 6 MP, bloody stool 6 Laparotomy Colon Large-1 - yes - yes - -
12 (M) 12 No 9 MP, abdominal pain 9 Col Colon Large-4 - yes - - yes -
13 (F) 12 No 10 MP, abdominal pain 10 CE SB Small - - - - yes -













frameshift mutation and resulted in a change in codon
161 from Ile to Asn and a termination at codon 163,
leading to partial loss of the kinase domain and
complete loss of the C-terminus. In Case 3, a 2-bp dele-
tion was detected (c943_944) and one G base was
inserted, which led to a Pro-to-Gly substitution at codon
315 and a partial loss of the C-terminus. Cases 12 and
13 had mutations similar to those of Case 3. In Case 4, a
one-base deletion (c397het_delG) was detected in exon
3, which led to a Val-to-Cys substitution, with a prema-
ture stop at codon 161. Case 6 had a heterozygous de
novo mutation with a G-to-A substitution at intron 6.
Case 9 had a frameshift mutation with a 2-bp deletion
(c.348–349delGT) in exon 2, which caused a Leu-to-Ile
substitution at codon 117 and a premature terminator at
codon 162, leading to partial loss of the kinase domain
Table 3 Summary of STK11 mutations identified in patients
Case no Incidence Age at onset Variation type Location Variation position Predicted consequence
1 Sporadic 1 y Frameshift Exon 4 c.481het_dupA p.I161Nfs*2
2 Sporadic 2 y Nonsense Exon 5 c.658C>C/T p.G220X
3 Sporadic 1 y Frameshift Exon 8 c.943_944het_delCCinsG p.P315Gfs*21
4 Sporadic 7 y Frameshift Exon 3 c.397het_delG p.V133Cfs*28
5 Family 3 y Missense Exon 7 c.890G>G/A p.R297K
6 Family 2 y Splice site Intron 6 c.862+1G>G/A -
7 Sporadic 6 y Missense Exon 8 c.1062C>C/G p.F354L
8 Family 6 y Splice site Intron 1 c.290+1G>G/A -
9 Sporadic 1 y Frameshift Exon 2 c.348_349het_delGT p.L117Ifs*45
10 Sporadic 6 m N N N N
11 Family 6 y Frameshift Exon 6 c.803_804het_delGGinsC p.G268Afs*19
12 Sporadic 2y Frameshift Exon 1 c.121_139del19insTT p.K41Lfs*116
13 Sporadic 1y ND ND ND ND
Novel variants are in bold font
N negative, ND not detected
Fig. 2 STK11 gene sequencing results. a The variant (481het_dupA) in exon 4 of the STK11 gene in Case 1. b Mutation c.658C > C/T in exon 5 of
Case 2. c Mutation c.943_944het_delCCinsG in exon 8 of Case 3. d The variant (c.397het_delG) in exon 3 of the STK11 gene in Case 4. e The
variant (c.890G > G/A) in exon 7 of the STK11 gene in Case 5. f The variant (c.862 + 1G > G/A) in intron 6 of the STK11 gene in Case 6. g Case 7
carries a c.1062C > C/G mutation in exon 8. h Mutation c.290 + 1G > G/A in intron 1 of Case 8. i The variant (c.348_349het_delGT) in exon 2 of
Case 9. j Case 11 carries a c.803_804het_delGGinsC mutation in exon 6. k Case 12 carries a c.121_139del19insTT mutation in exon 1. The red
arrows indicate the mutation sites
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and a complete loss of the α-helix of the C-terminus.
Case 2 possessed a novel mutation (c.658C > C/T) in
exon 5 of the STK11 gene that resulted in the produc-
tion of a truncated protein (Q220X). This mutation has
never been reported in Chinese PJS patients.
Furthermore, the gene mutations and the histories of
the available pedigree were also examined in the whole
family of Cases 1, 3, 5 and 6 (Fig. 3). Case 5’s father and
sister had the same mutation as Case 5. Case 6’s father
had the same mutation as Case 6. There were no STK11
gene mutations detected in the father of Case 2. The
father of Case 8 was also a PJS patient but could not be
included because he died of colon cancer at age 39. The
mother of Case 11 is also a PJS patient; however she
refused the STK11 gene test.
Discussion
PJS is a triad that includes MP, gastrointestinal polyposis
and an increased risk of cancer. The polyposis often
occurs in the intestinal tract but can appear anywhere.
The complications of PJS include chronic abdominal
pain, anemia due to polyp ulceration or infarction,
bloody stools, and acute intestinal intussusceptions that
require surgical intervention.
For children with PJS, the recent guidelines on when
and how to screen for polyps vary in different countries.
A Dutch surveillance recommendation suggests starting
with capsule endoscopy at age 10 and continuing with
capsule endoscopy every 2 to 3 years if no polyps are
identified [10]. A French group recommended that regu-
lar surveillance is recommended every 2 years for PJS
children over 8 years old with PJS [11]. An American
group suggested that surveillance should begin with en-
doscopy at approximately 4 to 5 years of age [6]. Our
research showed that the median age at first screening
in Chinese children with PJS was 6.5 years. Because
children have smaller lumen sizes than adults, smaller
polyps may potentially cause an obstruction or an intus-
susception. Therefore, in our study, polyps were classi-
fied as “large” at >1 cm and “giant” at >2 cm. Our
study showed that children with PJS had more endo-
scopic resections than laparotomies. These observa-
tions indicate that polypectomy with endoscopy is
safe, efficacious, and cost-effective for the manage-
ment of polyps in PJS patients. However, surgical re-
section may be employed for large polyps with non-
polypoid morphology, polyps in anatomic locations
that area not amenable to endoscopic removal, and
intussusception, and intestinal obstructions that can-
not be reversed [12].
Mutations in the STK11 gene, which is located on
chromosome 19p13.3, are the causative agent in PJS
patients. The STK11 protein is composed of three
major domains: the N-terminal non-catalytic domain
(encoded by amino acids 1–49), the catalytic kinase
domain (encoded by amino acids 49–309) and the C-
Fig. 3 Pedigrees of the four PJS families (Case 1, 3, 5, 6). Square: male; circle: female; black symbol: affected individual; white symbol: unaffected
individual. Asterisks indicate the family members with available genetic analyses. The proband in each pedigree is indicated by an arrow
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terminal non-catalytic regulatory domain (encoded by
amino acids 309–433) [13]. The N-terminal domain
contains the nuclear localization signal. The catalytic
kinase domain forms a complex with STe20-Related
Adaptor(STRAD) and scaffold protein 25 (MO25) to
maintain the activation of this kinase [14]. Variations
in PJS patients are mostly located in the catalytic do-
main region and cause dysfunctions in kinase activity,
thus disrupting the function of STK11.
In our study, we identified STK11 mutations in spor-
adic cases and in family members of Chinese children
with PJS. We reported seven novel mutations that have
never been reported in any database or in any published
articles. The different mutation types and sites in the
STK11 gene correlate with different complication risks.
Saloch et al. reported that truncation mutations in PJS
are associated with a larger number of polyps, surgical
interventions and cancers [15]. Our study similarly indi-
cates that children with frameshift mutations had more
gastrointestinal polyps and received more endoscopic
screenings and more surgical interventions. Schumacher
et al. [16] discovered that missense mutations in the C-
terminus and in regions VIB-VIII of the protein were
more frequently associated with malignancies. Wang et
al. reported that mutations affecting protein kinase do-
main XI, encoded in part by exon 7, correlated with a
90 % (9/10) incidence of gastrointestinal polyp dysplasia
[17]. Lim et al. suggested that mutations in exon 3 were
associated with a higher risk of cancer [18]. In another
study, Mehenni et al. found statistically significant evi-
dence correlating mutations in exon 6 with a higher risk
of cancer [19]. Thus, different exons and different muta-
tion types may play different roles in the effects of PJS.
No mutations were detected in one child with PJS in
our study. Germline mutations of STK11 can only be de-
tected in only 50–70 % of PJS patients [20]. Partial or
whole exon deletions can be identified through multi-
plex ligation-dependent probe amplification (MLPA) or
through quantitative polymerase chain reaction (qPCR)
in approximately 30 % of patients [21]. Other genes be-
sides 19p13.3 may also carry mutations. For example,
additional evidence has been found for the roles of
the 19q13.4 locus or other variants in LKB1-negative
PJS mutation carriers [22, 23]. Furthermore, high-
throughput sequencing technology, such as whole-
exon sequencing, may be a powerful tool for identifying
these causative variants.
Of the four known STK11 mutations, the de novo
p.G220X variant was found in Case 2, and it was located
in the catalytic kinase domain of the STK11 protein.
This mutations was previously reported in a study of
Japanese adults [24], and. Loss of kinase activity is
most likely responsible for the development of the PJS
phenotype. Case 2 developed more gastric polyps and
experienced anemia and underwent polypectomy three
times using endoscopic hemoclips. In Case 5, the mis-
sense mutation c.890 > G/A changed Arg to Lys at
codon 297. This de novo mutation of the STK11 gene
was previously unreported in Chinese populations, al-
though this mutation had been reported in a Dutch pa-
tient [25]. The missense mutation p.F354L in exon 8 of
STK11 gene that was identified in Case 7 that had been
previously reported only in Chinese adults [26] and the
mutation site was located in the C-terminal non-
catalytic regulatory domain. Case 7 has undergone poly-
pectomy twice using endoscopic hemoclips, in addition
to an operative intervention because of acute intussus-
ception. Loss of the C-terminal domain of STK11 leads
to the loss of cell polarity and hamartoma formation as a
result of inappropriate overgrowth of differentiated cells.
These mutations lead to impairments in both AMPK
signaling and LKB1 polarity function [27]. Case 8 carried
a de novo STK11 gene mutation that was previously un-
reported in Chinese populations, although it had been
reported in a French population [28].
Genotype-phenotype correlation studies have been de-
scribed in PJS patients. The frequency and spectrum of
the cancer risk in those with PJS are more than 4 times
the normal levels. The different germline variants of the
STK11 gene predispose patients to different disease
manifestations (e.g., numbers of polyps and times of on-
set of mucocutaneous pigmentation) and different risks
of cancer. Some researchers have demonstrated that mu-
tation types and locations are associated with the initial
clinical presentations, surgical interventions and cancers
experienced by PJS patients [15, 16]. However, those ob-
servations are based on relatively small patient numbers,
and more data are needed for confirmation. Genetic
diagnosis, in addition to surveillance by gastrointestinal
endoscopy, is a useful tool in prenatal diagnosis, the
clinical management of patients, and cancer surveillance.
Long-term follow-up data are needed to establish the
genotype/phenotype association with malignancy be-
cause these patients in present study are children, and
cancer is more often observed in adults [15].
Conclusion
Taken together, our data confirmed that polyps can
occur at an early age and in all parts of the gastroentero-
logical tract in children with PJS. We also found seven
novel and four recurrent STK11 gene mutations in
Chinese children with PJS. These results expand the data
on Chinese children with PJS with a variety of STK11
variants.
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